Based in France, DIAFIR is a startup founded in 2011. Brouky records 1 investor associated with the company.
DIAFIR develops point-of-care medical diagnostics using proprietary mid-infrared spectroscopy technology to rapidly analyze patient metabolic signatures, primarily serving healthcare providers with quick and cost-effective diagnostic tools.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.